VEGFA and acute myeloid leukemia: Both in vitro and in vivo investigations have revealed that VEGF-A was present in a high concentration in the bone marrow (BM) cells of AML patients and the vast majority of myeloblasts (>90%) could synthesise and secrete VEGF-A (Ghannadan et al, 2003).